Research and Patents in Regenerative Medicine
GNC in collaboration with Nichi In Centre for Regenerative Medicine (NCRM) has been working on cell based therapies and tissue engineering systems and has developed novel cell therapy solutions in several specialties; including ophthalmology, urology and orthopaedics.
One of our core strengths has been the possession of technology (both materials and methodologies) for processing, expanding and preservation of stem cells, precursor cells as well as mature cells. With our expertise with a range of biomaterials such as polymer scaffolds and nanocomposite gels, advantageous cell culture and tissue engineering are feasible without animal protein contamination.
１． “Gel film for corneal endothelial cell defect treatment” Japan Patent No. 5863089
Obtained a patent for gel film for culturing corneal endothelial cells for use in the treatment of defective corneal endothelial cells. Once this treatment is established, a mission to save “An-eye for Eyes” will be possible. This gel film is also patented in India. (www.cesbank.org)
2. “Novel cell therapy method for male urethral stricture” Japan Patent No. 6714247
BEES-HAUS (Buccal epithelium Expanded and Encapsulated in Scaffold-Hybrid Approach to Urethral Stricture)
This treatment method simplifies the otherwise required long clinical procedure, less painful patient with shorter hospital stay bringing down the healthcare burden, while providing longer duration of recurrence free status (https://onlinelibrary.wiley.com/doi/full/10.1111/iju.13852) Has a market potential of USD200 Million in US.
3. “Method of Enhancing Functions of Immune and Blood Cells by Preservation Solution Containing TGP and Microgravity Loading” Japan Patent No. 6757578
Obtained a patent for a method of enhancing the functions of immune cells and blood cells, by using a preserved solution containing TGP and microgravity.